Initial studies using RT-PCR targeting exons 11 and 15 alongside High-Resolution Melting Analysis (HRMA) identified BRAF mutations in approximately 5% of lung adenocarcinomas, with about 58% classified as V600E mutations [37]. Here, BRAF is linked to lung adenocarcinoma.